Citius Pharmaceuticals regains Nasdaq compliance on bid price rule

Citius Pharmaceuticals, Inc.

Received Nasdaq notice on Dec 18, 2024 confirming compliance with Listing Rule 5550(a)(2).
Stock closed at $1.00 or more for 12 consecutive trading days from Nov 26 to Dec 12, 2024.
Nasdaq stated the matter is now closed.

item 8.01

Citius Pharmaceuticals, Inc. filing history →

Source: SEC EDGAR

accession 0001213900-24-111212

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.